Highlights
EFCCA Magazine 1/2025
The latest edition of EFCCA Magazine is here, packed with updates on what EFCCA has been working on over the past months, insights from our member associations, and an article by Professor Claudio Fiocchi...
EFCCA Talk: IUS - Intestinal Ultrasound, a Promising Alternative to Endoscopy?
This non-invasive technique is emerging as a valuable tool for diagnosis, treatment, and disease monitoring in IBD patients.
Stay connected: Follow us on Instagram!
As we embark on a new year, our communication team has been working behind the scenes to bring you closer to the EFCCA community.
Patients Participation in HTA: Final Report Released
Following the success of our HTA conference at UEGW last October, EFCCA is pleased to share the final report from a two-round consultation with stakeholders and experts.
INTERCEPT: Pioneering the future of Crohn’s disease prevention
EFCCA is proud to partner in the innovative INTERCEPT IHI project, which aims to revolutionise the approach to Crohn’s dvisease by focusing on prevention and early intervention.
EFCCA Talk: "Living with Fibrosis: Challenges, Treatments and Innovations"
Register now to an exclusive webinar as part of the Horizon Europe Project FIBROTARGET. This engaging session will bring together leading experts and patient...
Upcoming EFCCA Conference at ECCO Congress 2025 in Berlin
We are excited to invite you to the upcoming EFCCA Conference "What do IBD patients find important in their treatment? - Results from a global Patient
Preference survey” that will take place on...
New European Research Project “PerPrev-CID”
Aiming to revolutionise personalised prevention and early treatment in chronic inflammatory diseases (CIDs), the PerPrev-CID project focuses on advancing risk prediction, early detection of disease progression, and innovative preventive approaches in...
Empowering Patient Voices in Health Technology Assessment: EFCCA's Conference at UEG Week 2024
On 12 October 2024, EFCCA organised a conference during UEG Week (Vienna) titled: "How can patients play a crucial role in medicines-related decision-making? An open dialogue with stakeholders and the presentation of the EFCCA...
1st GlycanTrigger Patients Symposium
Registrations are open for the 1st GlycanTrigger Patients Symposium, an important event we are co-organising together with the Portuguese Society for Innovation (SPI), focused on collaborative discussions around strategies for predicting and...